The epilepsy device market is experiencing significant growth, driven by technological advancements, increased demand for non-invasive treatments, and AI-powered solutions.Austin, Dec. 13, 2024 (GLOBE ...
Medical technology company Nyxoah has officially launched its Genio system, a small implant that has the potential to treat ...
In a report released today, Edward White from H.C. Wainwright reiterated a Buy rating on Nyxoah (NYXH – Research Report), with a price target ...
Genio is now covered under the NHS Specialised Services Devices Programme (SSDP), enabling access ... “Today represents an ...
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Complex Regional Pain Syndrome ...